NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management
From modern perspective, hyperuricemia should be considered as a trigger of inflammatory activity in tissues and organs, leading to the formation of tophi, arthropathy, kidneys and cardiovascular system damage. Similarly, hypercholesterolemia, a proven factor in atherogenesis-far from all patients l...
Saved in:
Main Authors: | P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2024-07-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/3018 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asymptomatic hyperuricemia and gout: Are there any differences (data from a pilot case-control study)
by: M. S. Eliseev, et al.
Published: (2025-07-01) -
Xanthine oxidase inhibitors in asymptomatic hyperuricemia
by: O. V. Zhelyabina, et al.
Published: (2019-10-01) -
NLRP3 inflammasome: a key player in neonatal brain injury
by: Cagla Kiser, et al.
Published: (2025-07-01) -
NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01) -
Mechanisms of cartilage damage in gout and hyperuricemia
by: E. V. Panina
Published: (2024-04-01)